Accès gratuit
Ann. Fr. Med. Urgence
Volume 12, Numéro 6, Novembre 2022
Page(s) 383 - 390
Section Mise au point / Update
Publié en ligne 28 octobre 2022
  • Rothberg MB (2022) Community-acquired pneumonia. Ann Intern Med 175:49–64 [Google Scholar]
  • Tattevin P (2015) Pneumonies communautaires : épidémiologie, clinique, traitement. J Anti-Infect 17:20-4 [CrossRef] [Google Scholar]
  • Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71–9 [CrossRef] [PubMed] [Google Scholar]
  • Dandachi D, Rodriguez-Barradas MC (2018) Viral pneumonia: etiologies and treatment. J Invest 66:957–65 [Google Scholar]
  • Jain S, Self WH, Wunderink RG, et al (2015) Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:415–27 [CrossRef] [PubMed] [Google Scholar]
  • Alimi Y, Lim WS, Lansbury L, et al (2017) Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol 95:26–35 [CrossRef] [PubMed] [Google Scholar]
  • Lansbury L, Lim B, Baskaran V, Lim WS (2020) Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 81:266–75 [CrossRef] [PubMed] [Google Scholar]
  • Langford BJ, So M, Raybardhan S, et al (2020) Bacterial coinfection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 26:1622–9 [CrossRef] [PubMed] [Google Scholar]
  • Lhommet C, Garot D, Grammatico-Guillon L, et al (2020) Predicting the microbial cause of community-acquired pneumonia: can physicians or a data-driven method differentiate viral from bacterial pneumonia at patient presentation? BMC Pulm Med 20:62 [CrossRef] [PubMed] [Google Scholar]
  • Gardner JG, Bhamidipati DR, Rueda AM, et al (2016) The white blood cell count and prognosis in pneumococcal pneumonia. Open Forum Infect Dis 3:1245 [CrossRef] [Google Scholar]
  • Lanini S, Montaldo C, Nicastri E, et al (2020) COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One 15:e0244129 [CrossRef] [PubMed] [Google Scholar]
  • Henry BM, de Oliveira MHS, Benoit S, et al (2020) Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 58:1021–8 [CrossRef] [PubMed] [Google Scholar]
  • Yunus I, Fasih A, Wang Y (2018) The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One 13:e0206527 [CrossRef] [PubMed] [Google Scholar]
  • Hohn A, Balfer N, Heising B, et al (2018) Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock. Ann Intensive Care 8:68 [CrossRef] [PubMed] [Google Scholar]
  • Huang H-B, Peng J-M, Weng L, et al (2017) Procalcitoninguided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis. Ann Intensive Care 7:114 [CrossRef] [PubMed] [Google Scholar]
  • Luan Y, Yao Y (2018) The clinical significance and potential role of C-Reactive Protein in chronic inflammatory and neurodegenerative diseases. Front Immunol 9:1302 [CrossRef] [PubMed] [Google Scholar]
  • Guo S, Mao X, Liang M (2018) The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia. Respir Res 19:193 [CrossRef] [PubMed] [Google Scholar]
  • Porfyridis I, Georgiadis G, Vogazianos P, et al (2014) C-Reactive Protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia. Respir Care 59:574–81 [CrossRef] [PubMed] [Google Scholar]
  • Le Bel J, Hausfater P, Chenevier-Gobeaux C, et al (2015) Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan. Crit Care 19:366 [CrossRef] [PubMed] [Google Scholar]
  • Loubet P, Tubiana S, Claessens YE, et al (2020) Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication. Clin Microbiol Infect 26:382.e1-382.e7 [CrossRef] [Google Scholar]
  • Nouvenne A, Ticinesi A, Folesani G, et al (2016) The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study. BMC Geriatr 16:16 [CrossRef] [PubMed] [Google Scholar]
  • Ebell MH, Bentivegna M, Cai X, et al (2020) Accuracy of biomarkers for the diagnosis of adult community-acquired pneumonia: a meta-analysis. Acad Emerg Med 27:195–206 [CrossRef] [PubMed] [Google Scholar]
  • Bernstein D, Coster D, Berliner S, et al (2021) C-reactive protein velocity discriminates between acute viral and bacterial infections in patients who present with relatively low CRP concentrations. BMC Infect Dis 21:1210 [CrossRef] [PubMed] [Google Scholar]
  • Luan Y, Yin C, Yao Y (2021) Update advances on C-Reactive Protein in COVID-19 and other viral infections. Front Immunol 12:720363 [CrossRef] [PubMed] [Google Scholar]
  • Hausfater P, Charles P-E (2021) Le dosage de la procalcitonine peut-il être utile à la prise en charge d’une infection à SARSCoV-2 aux urgences et en réanimation ? Ann Fr Med Urg 11:243–8 [CrossRef] [Google Scholar]
  • Euser SM, Badoux P, Kracht-Kosten L, Yzerman EPF (2018) Evaluation of the Sofia Streptococcus pneumoniae FIA test for the detection of S. pneumoniae antigen in urine. J Med Microbiol 67:1743–6 [CrossRef] [PubMed] [Google Scholar]
  • Beraud L, Gervasoni K, Freydiere AM, et al (2015) Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers. Eur J Clin Microbiol Infect Dis 34:1803–7 [CrossRef] [PubMed] [Google Scholar]
  • Sinclair A, Xie X, Teltscher M, Dendukuri N (2013) Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by streptococcus pneumoniae. J Clin Microbiol 51:2303–10 [CrossRef] [PubMed] [Google Scholar]
  • Matta M, Kernéis S, Day N, et al (2010) Do clinicians consider the results of the BinaxNOW Streptococcus pneumoniae urinary antigen test when adapting antibiotic regimens for pneumonia patients? Clin Microbiol Infect 16:1389–93 [CrossRef] [PubMed] [Google Scholar]
  • Reed WW, Byrd GS, Gates RH, et al (1996) Sputum gram’sstain in community-acquired pneumococcal pneumonia. A meta-analysis. West J Med 165:197–204 [PubMed] [Google Scholar]
  • Ogawa H, Kitsios GD, Iwata M, Terasawa T (2020) Sputum gram stain for bacterial pathogen diagnosis in community-acquired pneumonia: a systematic review and bayesian metaanalysis of diagnostic accuracy and yield. Clin Infect Dis 71:499–513 [CrossRef] [PubMed] [Google Scholar]
  • Del Rio-Pertuz G, Gutiérrez JF, Triana AJ, et al (2019) Usefulness of sputum gram stain for etiologic diagnosis in community-acquired pneumonia: a systematic review and meta-analysis. BMC Infect Dis 19:403 [CrossRef] [PubMed] [Google Scholar]
  • Rosón B, Carratalà J, Verdaguer R, et al (2000) Prospective study of the usefulness of sputum gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 31:869–74 [CrossRef] [PubMed] [Google Scholar]
  • Campbell SG, Marrie TJ, Anstey R, et al (2003) The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 123:1142–50 [CrossRef] [PubMed] [Google Scholar]
  • Waterer GW, Wunderink RG (2001) The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 95:78–82 [CrossRef] [PubMed] [Google Scholar]
  • Afshar N, Tabas J, Afshar K, Silbergleit R (2009) Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review. J Hosp Med 4:112–23 [CrossRef] [PubMed] [Google Scholar]
  • Metlay JP, Waterer GW, Long AC, et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the american thoracic society and infectious diseases society of America. Am J Respir Crit Care Med 200:e45–67 [CrossRef] [PubMed] [Google Scholar]
  • Makam AN, Auerbach AD, Steinman MA (2014) Blood culture Use in the emergency department in patients hospitalized for community-acquired pneumonia. JAMA Intern Med 174:803–6 [CrossRef] [PubMed] [Google Scholar]
  • Hammond SP, Gagne LS, Stock SR, et al (2012) Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods. J Clin Microbiol 50:3216–21 [CrossRef] [PubMed] [Google Scholar]
  • Babady NE, England MR, Jurcic Smith KL, et al (2018) Multicenter evaluation of the ePlex respiratory pathogen panel for the detection of viral and bacterial respiratory tract pathogens in nasopharyngeal swabs. J Clin Microbiol 56:e01658–17 [CrossRef] [PubMed] [Google Scholar]
  • Leber AL, Lisby JG, Hansen G, et al (2020) Multicenter evaluation of the QIAstat-Dx respiratory panel for detection of viruses and bacteria in nasopharyngeal swab specimens. J Clin Microbiol 58:e00155–20 [CrossRef] [PubMed] [Google Scholar]
  • Busson L, Mahadeb B, De Foor M, et al (2017) Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza. Diagn Microbiol Infect Dis 87:238–42 [CrossRef] [PubMed] [Google Scholar]
  • Farfour E, Roux A, Ballester M, et al (2020) Improved performances of the second generation of the ID NOW influenza A&B 2® and comparison with the GeneXpert®. Eur J Clin Microbiol Infect Dis 39:1681–6 [CrossRef] [PubMed] [Google Scholar]
  • Brendish NJ, Malachira AK, Armstrong L, et al (2017) Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 5:401–11 [CrossRef] [PubMed] [Google Scholar]
  • Brendish NJ, Malachira AK, Beard KR, et al (2018). Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial. Eur Respir J 52:1800555 [CrossRef] [PubMed] [Google Scholar]
  • Andrews D, Chetty Y, Cooper BS, et al (2017) Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasirandomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis 17:671 [CrossRef] [PubMed] [Google Scholar]
  • Shengchen D, Gu X, Fan G, et al (2019) Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial. Clin Microbiol Infect 25:1415–21 [CrossRef] [PubMed] [Google Scholar]
  • Bouzid D, Casalino E, Mullaert J, et al (2021) Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial. J Antimicrob Chemother 76:iii20–7 [CrossRef] [PubMed] [Google Scholar]
  • Hopstaken RM, Witbraad T, van Engelshoven JMA, Dinant GJ (2004) Inter-observer variation in the interpretation of chest radiographs for pneumonia in community-acquired lower respiratory tract infections. Clin Radiol 59:743–52 [CrossRef] [PubMed] [Google Scholar]
  • Albaum MN, Hill LC, Murphy M, et al (1996) Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators. Chest 110:343–50 [CrossRef] [PubMed] [Google Scholar]
  • Campbell SG, Murray DD, Hawass A, et al (2005) Agreement between emergency physician diagnosis and radiologist reports in patients discharged from an emergency department with community-acquired pneumonia. Emerg Radiol 11:242–6 [CrossRef] [PubMed] [Google Scholar]
  • Esayag Y, Nikitin I, Bar-Ziv J, et al (2010) Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am J Med 123:88.e1-5 [CrossRef] [Google Scholar]
  • Syrjälä H, Broas M, Suramo I, et al (1998) High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 27:358–63 [CrossRef] [PubMed] [Google Scholar]
  • Claessens Y-E, Debray M-P, Tubach F, et al (2015) Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am J Respir Crit Care Med 192:974–82 [CrossRef] [PubMed] [Google Scholar]
  • Prendki V, Scheffler M, Huttner B, et al (2018) Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study. Eur Respir J 51:1702375 [CrossRef] [PubMed] [Google Scholar]
  • Llamas-Álvarez AM, Tenza-Lozano EM, Latour-Pérez J (2017) Accuracy of lung ultrasonography in the diagnosis of pneumonia in adults: systematic review and meta-Analysis. Chest 151:374–82 [CrossRef] [PubMed] [Google Scholar]
  • Kim EA, Lee KS, Primack SL, et al (2002) Viral pneumonias in adults: radiologic and pathologic findings. RadioGraphics 22: S137–49 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.